FR2344558B1 - - Google Patents

Info

Publication number
FR2344558B1
FR2344558B1 FR7707487A FR7707487A FR2344558B1 FR 2344558 B1 FR2344558 B1 FR 2344558B1 FR 7707487 A FR7707487 A FR 7707487A FR 7707487 A FR7707487 A FR 7707487A FR 2344558 B1 FR2344558 B1 FR 2344558B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7707487A
Other languages
French (fr)
Other versions
FR2344558A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of FR2344558A1 publication Critical patent/FR2344558A1/fr
Application granted granted Critical
Publication of FR2344558B1 publication Critical patent/FR2344558B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR7707487A 1976-03-16 1977-03-14 Thienamycine sulfoxyde et sulfone utiles comme medicaments Granted FR2344558A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66732376A 1976-03-16 1976-03-16

Publications (2)

Publication Number Publication Date
FR2344558A1 FR2344558A1 (fr) 1977-10-14
FR2344558B1 true FR2344558B1 (Direct) 1980-06-13

Family

ID=24677763

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7707487A Granted FR2344558A1 (fr) 1976-03-16 1977-03-14 Thienamycine sulfoxyde et sulfone utiles comme medicaments

Country Status (8)

Country Link
JP (1) JPS52111591A (Direct)
CH (1) CH630086A5 (Direct)
DE (1) DE2711223A1 (Direct)
DK (1) DK90277A (Direct)
FR (1) FR2344558A1 (Direct)
GB (1) GB1551672A (Direct)
NL (1) NL7702183A (Direct)
SE (1) SE7702370L (Direct)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1577725A (en) * 1976-06-30 1980-10-29 Beecham Group Ltd Azetidinone derivatives
EP0002564B1 (en) * 1977-11-12 1984-06-20 Beecham Group Plc Derivatives of 7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid, their preparation, pharmaceutical compositions containing them and intermediates
US4341705A (en) 1980-10-10 1982-07-27 Merck & Co., Inc. Thienamycin derivatives
JPS61236785A (ja) * 1985-04-15 1986-10-22 Sankyo Co Ltd アゼチジノン誘導体

Also Published As

Publication number Publication date
JPS52111591A (en) 1977-09-19
FR2344558A1 (fr) 1977-10-14
NL7702183A (nl) 1977-09-20
CH630086A5 (en) 1982-05-28
DK90277A (da) 1977-09-17
GB1551672A (en) 1979-08-30
SE7702370L (sv) 1977-09-17
DE2711223A1 (de) 1977-10-27

Similar Documents

Publication Publication Date Title
DK138437C (Direct)
FR2339975B2 (Direct)
DE2656815C3 (Direct)
FR2356649B1 (Direct)
JPS52162359U (Direct)
JPS5538659Y2 (Direct)
FR2344558B1 (Direct)
JPS5428800B2 (Direct)
JPS5376298U (Direct)
JPS5327747U (Direct)
JPS5517198Y2 (Direct)
JPS5722745Y2 (Direct)
JPS5521892Y2 (Direct)
JPS568077B2 (Direct)
JPS5293962U (Direct)
JPS52129716U (Direct)
JPS5731371Y2 (Direct)
FR2344184B2 (Direct)
JPS5351071U (Direct)
JPS5297496U (Direct)
JPS52112830U (Direct)
JPS52149374U (Direct)
JPS52162258U (Direct)
JPS5273824U (Direct)
CS177791B1 (Direct)

Legal Events

Date Code Title Description
ST Notification of lapse